Oxcarbazepine Prices: Trend, Demand & Supply, Market Analysis | ChemAnalyst

North America:

The Oxcarbazepine API price remained stable in the US throughout the third quarter of 2023. July witnessed a consistent downward trend in prices, but as Q3 progressed, the downstream healthcare sector experienced a moderate surge in demand. Despite high local spot market inventories of Oxcarbazepine, merchants ensured ample supply to meet customer needs. Until late August 2023, many retailers refrained from placing new orders due to rising shipping costs. Prices steadily increased towards the end of September 2023, influenced by a steady supply chain response to manufacturing orders. The rise in Acetic acid prices, a key raw material, further fueled this trend. Additionally, the continuously increasing costs of fuel and energy contributed to the overall uptick in Oxcarbazepine prices by the end of September.

Asia Pacific:

In the APAC region, especially in the Indian market, Oxcarbazepine API prices remained subdued in July during the third quarter of 2023. The decrease in prices of essential raw materials like Acetic Acid, crucial for Oxcarbazepine production, contributed to the overall reduction in Oxcarbazepine prices. Persistent decreases in consumption from end-user healthcare and pharmaceutical industries led to a higher product accumulation. By August 2023, suppliers shifted focus to replenish their inventories. India’s Purchasing Managers’ Index (PMI) for August 2023 indicated continued expansion in both the manufacturing and services sectors. Looking ahead to September, India’s Consumer Price Index (CPI) showed a 5.90% increase compared to September 2022, reflecting relatively high inflation. Steady supply, regular manufacturing pace, and constant imports until the end of September 2023, including from China, maintained sufficient stock levels in the market.

Europe:

In the German market during the third quarter of 2023, Oxcarbazepine prices followed a trajectory similar to the APAC region. Prices steadily declined from July, increasing the likelihood of excess inventory and weakening demand. Exporting countries’ increased output from Oxcarbazepine API production in the previous month resulted in a surplus, leading to a global price decline in July, extending until the middle of Q3. However, as September concluded, the market experienced a moderate uptick in Oxcarbazepine prices. This led to a steady rise in inquiries, balancing the overall supply side. Market analysts noted that buyers placed orders based on anticipated long-term growth, and Germany’s high energy costs contributed to the rise in market prices. Additionally, the euro’s recent depreciation against the US dollar increased costs for purchasers in the eurozone, adding to the price increase in September 2023.